Report received that end user has redenned, open, weeping area since may of 2012.Has used lotrimin spray on area under durahesive barrier without positive results.The area affected is under the durahesive barrier only.It does not extend passed the tape collar.Further information regarding patient outcome was not available.
|
Convatec is submitting this report as a result of remediation activities related to the fda 483 issues april 16, 2014.Device(s) listed in this report is (are) used for treatment, not diagnosis.Any additional information received regarding this event after filing this report shall be filed on a supplemental mdr.Analysis is taken from a trending report of evaluations or adverse events finalized may 2011.The data presented is from three different product applications.The report states that there are no significant trends.After further investigation, the initial lot information obtained was determined as invalid under the current system.
|